Support our Foundation of Myology project
1655 news items
French experience with Zolgensma® in type I SMA
On 07/01/2025
Between June 2019 and June 2022, 95 children with treatment-naive type I SMA were identified in one of the 23 neuromuscular disease centres of reference.…
Use of psychostimulants to treat daytime hypersomnolence in myotonic dystrophies
On 06/01/2025
A Cochrane review of clinical trials evaluating psychostimulant drugs in myotonic dystrophies was published in November 2024. Six clinical trials were selected, involving 136 participants.…
A natural history of FSHD established after five years of observation
On 06/01/2025
Dutch researchers have designed a follow-up protocol for patients suffering from facioscapulohumeral muscular dystrophy (FSHD) in order to gain a better understanding of the natural…
ERN EURO-NMD, 9 Jan.: Dr. Teresinha Evangelista (France)
On 03/01/2025
The role of biopsy in Autophagic Myopathies Thursday 09 January 2025 – 16:00 – 17:00 Paris time Dr. Teresinha Evangelista (Institute of Myology & Pitié…
DMD: a summary of the factors correlated with cardiac damage
On 02/01/2025
A review of the literature on predictors of cardiac involvement in Duchenne muscular dystrophy included 33 articles concerning 9,232 patients. Most (76%) were retrospective studies,…
NDUFA11, a possible autoantigen in inclusion body myositis
On 31/12/2024
An international study involving the Nice University Hospital and the Pitié-Salpêtrière Hospital : evaluated IgG reactivity to a panel of 357 proteins in a total…
New European recommendations for Pompe disease
On 30/12/2024
The European Reference Network for Metabolic Diseases (MetabERN) has drawn up new recommendations for Pompe disease, the most common muscular glycogenosis: experts in the field…
Towards a better understanding of myopathy linked to the DNAJB4 gene
On 29/12/2024
An international consortium of researchers and clinicians report the clinical and biological data of patients diagnosed with DNAJB4-related myopathy: 5 families of distinct and unrelated…
For once, a heterozygous variant of the TTN gene can lead to a dominant myopathy
On 28/12/2024
The 14 members (eight affected and six healthy) of a family with autosomal dominant myopathy were examined in detail: the patients presented the same picture…
Danon disease: a single-centre Chinese retrospective study of 29 paediatric cases
On 27/12/2024
Between July 2014 and December 2023, 21 boys and 8 girls undergoing follow-up at a paediatric cardiology centre in Shanghai were genetically diagnosed with Danon…
Becker myopathy: a more specific mouse model
On 26/12/2024
A new rat model of Becker muscular dystrophy, with a deletion of exons 45-47 of the Dmd gene, has been developed by a French team…
Searching for markers of myasthenia gravis in French National Health Insurance data
On 24/12/2024
Over the period 2013-2020, 14,459 people in France received reimbursements for care related to autoimmune myasthenia gravis, including 6,354 for the first time. Of these,…
Disease progression in BMD depends on the type of deletion
On 23/12/2024
A retrospective natural history study of 943 patients with Becker myopathy (BMD) followed in 17 Italian neuromuscular centres provides information on the correlation between genetic…
Recommendations for cardiac monitoring of adults with canalopathy on mexiletine
On 20/12/2024
Cardiac monitoring is recommended in adults with muscular canalopathy treated for myotonia with mexiletine (Namuscla®), due to a possible pro-arrhythmic effect of the product. To…
Viltolarsen slows the decline in respiratory function in walking and non-walking patients
On 19/12/2024
A drug targeting exon 53 skipping of the DMD gene authorised in the United States and Japan, viltolarsen was evaluated for 48 weeks (80mg/kg/week) in…
Real-life data for gene therapy in SMA: the German-speaking area experience
On 17/12/2024
A transnational registry containing real-life data from patients with SMN1-related proximal spinal muscular atrophy (SMA) has been set up in Germany, Austria and German-speaking Switzerland:…
Dimitrios Kourtzas awarded Master Prize at JSFM 2024 – Interview
On 16/12/2024
Dimitrios Kourtzas has been awarded the Master’s Prize for his research project on collagen VI (COLVI)-related disorders at the JSFM 2024. He just started…
CAR-T cells to treat severe forms of Lambert-Eaton syndrome
On 16/12/2024
German researchers report the case of a patient with Lambert-Eaton syndrome (or LEMS, a presynaptic disorder of the neuromuscular junction very often of paraneoplastic origin)…
Report on the ‘1,000 researchers in schools’ operation
On 13/12/2024
The 12th edition of the ‘1,000 researchers in schools’ operation has just come to an end. This year it ran from 4 November to 6…
New data on life expectancy in DM2
On 13/12/2024
Of the 125 Dutch patients with myotonic dystrophy type 2 (DM2) recorded in the Dutch neuromuscular database, 26 died between 2000 and 2023 : the…